Home Authors Posts by Winway Health Desk

Winway Health Desk

11623 POSTS 0 COMMENTS

BCBS of Kansas City sues Covid-19 testing provider over alleged price...

Blue Cross and Blue Shield of Kansas City has filed a lawsuit accusing GS Labs, a provider of Covid-19 testing, of duping insurers into...

Only 5% hospitals are compliant with price transparency rule. Here’s how...

More than six months after the federal hospital price transparency rule went into effect, few facilities are fully compliant. Last week, The Washington Post...

As GlaxoSmithKline works to get Shingrix back on track, an FDA...

In response to the coronavirus pandemic knocking Shingrix off its juggernaut course, GlaxoSmithKline plans a “relaunch” to get the rising star vaccine back on...

Bristol Myers pulls Opdivo for use in liver cancer amid broader...

  Bristol Myers Squibb is withdrawing its blockbuster cancer immunotherapy from use in liver cancer, the latest drug pulled from the market amid broader FDA...

Despite JAK ‘anxiety,’ ICER experts overwhelmingly back Incyte’s ruxolitinib cream in...

Officials may have concerns about JAK inhibitor safety overall, but the case for Incyte's ruxolitinib cream in atopic dermatitis looks good, experts convened by the Institute for...

How wearable devices empower healthcare providers

According to the Association of American Medical Colleges, there will be an estimated shortage of between 37,800 and 124,000 primary and specialty-care physicians by...

Better together: McCann and FCB health chiefs talk strategy and strengths...

With 39 agencies now under its collective umbrella, there aren’t many pharma marketing challenges that the new IPG Health can’t address. And that’s the...

Look out, Lilly: Biogen’s Aduhelm likely won’t be the only Alzheimer’s...

When the Biden administration eventually makes its decision over whether Medicare will cover the controversial and costly Alzheimer’s drug Aduhelm, Biogen shouldn’t be the...

Pfizer, Johnson & Johnson settle high-profile Remicade biosim lawsuit on undisclosed...

For nearly four years, pharmaceutical heavyweights Johnson & Johnson and Pfizer have sparred in court over competitive dynamics of the biosimilar industry, demanding the attention...

FDA rejects Incyte cancer drug, asking for more data to show...

  An Incyte drug developed to treat a rare type of anal cancer still has a shot at FDA approval, but the company needs to...
0FansLike
68,639FollowersFollow
75,100SubscribersSubscribe

EDITOR PICKS